A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy

Pancreatic ductal adenocarcinoma (PDA) is a clinically challenging disease with limited treatment options. Despite a small percentage of cases with defective mismatch DNA repair (dMMR), PDA is included in the most immune‐resistant cancer types that are poorly responsive to immune checkpoint blockade...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhuolong, Van der Jeught, Kevin, Li, Yujing, Sharma, Samantha, Yu, Tao, Moulana, Ishara, Liu, Sheng, Wan, Jun, Territo, Paul R., Opyrchal, Mateusz, Zhang, Xinna, Wan, Guohui, Lu, Xiongbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427404/
https://www.ncbi.nlm.nih.gov/pubmed/37271874
http://dx.doi.org/10.1002/advs.202300548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427404/
https://www.ncbi.nlm.nih.gov/pubmed/37271874
http://dx.doi.org/10.1002/advs.202300548

Ejemplares similares